202 related articles for article (PubMed ID: 27720342)
21. An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals.
Klaric JS; Beltran TA; McClenathan BM
Mil Med; 2019 Mar; 184(Suppl 1):126-132. PubMed ID: 30901393
[TBL] [Abstract][Full Text] [Related]
22. Influenza vaccination among adults with asthma findings from the 2007 BRFSS survey.
Lu PJ; Euler GL; Callahan DB
Am J Prev Med; 2009 Aug; 37(2):109-15. PubMed ID: 19589448
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness of shingles vaccine among Albertans aged 50 years or older: A retrospective cohort study.
McDonald BM; Dover DC; Simmonds KA; Bell CA; Svenson LW; Russell ML
Vaccine; 2017 Dec; 35(50):6984-6989. PubMed ID: 29128385
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates.
Eid DD; Meagher RC; Lengel AJ
Consult Pharm; 2015 Aug; 30(8):459-62. PubMed ID: 26260642
[TBL] [Abstract][Full Text] [Related]
25. Vaccination Coverage Among Adults With Diagnosed Diabetes: United States, 2015.
Villarroel MA; Vahratian A
NCHS Data Brief; 2016 Dec; (265):1-8. PubMed ID: 27930282
[TBL] [Abstract][Full Text] [Related]
26. When zoster hits close to home: Impact of personal zoster awareness on zoster vaccine uptake in the U.S.
Harpaz R; Leung J
Vaccine; 2017 Jun; 35(27):3457-3460. PubMed ID: 28528766
[TBL] [Abstract][Full Text] [Related]
27. The essential role of pharmacists facilitating vaccination in older adults: the case of Herpes Zoster.
Tak CR; Marciniak MW; Savage A; Ozawa S
Hum Vaccin Immunother; 2020; 16(1):70-75. PubMed ID: 31369322
[TBL] [Abstract][Full Text] [Related]
28. Cost Effectiveness of a Shingles Vaccine Booster for Currently Vaccinated Adults in the U.S.
Le P; Rothberg MB
Am J Prev Med; 2017 Dec; 53(6):829-836. PubMed ID: 29153126
[TBL] [Abstract][Full Text] [Related]
29. Herpes zoster vaccine awareness among people ≥ 50 years of age and its implications on immunization.
Javed S; Javed F; Mays RM; Tyring SK
Dermatol Online J; 2012 Aug; 18(8):2. PubMed ID: 22948052
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Hornberger J; Robertus K
Ann Intern Med; 2006 Sep; 145(5):317-25. PubMed ID: 16954357
[TBL] [Abstract][Full Text] [Related]
31. Insurance reimbursements for recombinant zoster vaccine in the private sector.
Leidner AJ; Tang Z; Guo A; Anderson TC; Tsai Y
Vaccine; 2021 Aug; 39(36):5091-5094. PubMed ID: 34348844
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study.
Baxter R; Bartlett J; Fireman B; Marks M; Hansen J; Lewis E; Aukes L; Chen Y; Klein NP; Saddier P
Am J Epidemiol; 2018 Jan; 187(1):161-169. PubMed ID: 29309521
[TBL] [Abstract][Full Text] [Related]
33. [Shingles vaccine: which recommendations in 2014?].
Vionnet J; Hart K; Spertini F
Rev Med Suisse; 2014 Apr; 10(426):869-72, 874-5. PubMed ID: 24834646
[TBL] [Abstract][Full Text] [Related]
34. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
[TBL] [Abstract][Full Text] [Related]
35. State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.
Ahluwalia IB; Mack KA; Murphy W; Mokdad AH; Bales VS
MMWR Surveill Summ; 2003 Aug; 52(8):1-80. PubMed ID: 14532868
[TBL] [Abstract][Full Text] [Related]
36. Scarier than the flu shot? : The social determinants of shingles and influenza vaccinations among U.S. older adults.
Vogelsang EM; Polonijo AN
Vaccine; 2022 Nov; 40(47):6747-6755. PubMed ID: 36220715
[TBL] [Abstract][Full Text] [Related]
37. Herpes zoster knowledge, prevalence, and vaccination rate by race.
Joon Lee T; Hayes S; Cummings DM; Cao Q; Carpenter K; Heim L; Edwards H
J Am Board Fam Med; 2013; 26(1):45-51. PubMed ID: 23288280
[TBL] [Abstract][Full Text] [Related]
38. Low Rates of Vaccination for Herpes Zoster in Older People Living With HIV.
Erlandson KM; Streifel A; Novin AR; Hawkins KL; Foster C; Langness J; Bessesen M; Falutz J; Moanna A; Looney D; Johns ST; Nguyen JB; Oxman MN; Levin MJ
AIDS Res Hum Retroviruses; 2018 Jul; 34(7):603-606. PubMed ID: 29661022
[TBL] [Abstract][Full Text] [Related]
39. Disparities in Preconception Health Indicators -
Behavioral Risk Factor Surveillance System, 2013-2015, and Pregnancy Risk Assessment Monitoring System, 2013-2014.
Robbins C; Boulet SL; Morgan I; D'Angelo DV; Zapata LB; Morrow B; Sharma A; Kroelinger CD
MMWR Surveill Summ; 2018 Jan; 67(1):1-16. PubMed ID: 29346340
[TBL] [Abstract][Full Text] [Related]
40. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
